Comparison of two fixed activities of radioiodine therapy (370 vs. 555 MBq) in patients with Graves' disease

Hormones

Volumn 8, Issue 4, 2009, Pages 273-278

  Collier, Andrew ^a   Ghosh, Sujoy ^a   Hair, Mario ^a   Malik, Iqbal ^a   McGarvie, Jim ^a  

^a AYR HOSPITAL   (United Kingdom)

Author keywords

Graves' disease; Hyperthyroidism; Hypothyroidism; Radioiodine therapy

Indexed keywords

CARBIMAZOLE; IODINE 131; PROPYLTHIOURACIL; THYROTROPIN; THYROXINE;

ADULT; AGED; ARTICLE; CLINICAL ASSESSMENT; CLINICAL EFFECTIVENESS; COMPARATIVE STUDY; DRUG DOSE COMPARISON; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; GOITER; GRAVES DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; RADIOACTIVITY; RASH; RETROSPECTIVE STUDY; SEX DIFFERENCE; THERAPY EFFECT; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; TREATMENT OUTCOME; TREATMENT RESPONSE; UNITED KINGDOM;

EID: 74849136464     PISSN: 11093099     EISSN: None     Source Type: Journal    
DOI: 10.14310/horm.2002.1243     Document Type: Article

References (22)

1. Solomon B, Glinoer D, Lagasse R, Wartofsky L, 1990 Current trends in the management of Graves' disease. J Clin Endocrinol Metab 70: 1518-1524.
2. Radioiodine in the management of benign thyroid disease 2007. Clinical guidelines. Report of a Working Party. The Royal College of Physicians of London.
3. Hedley AJ, Lazarus JH, McGhee SM, et al, 1992, Treatment of hyperthyroidism by radioactive iodine. Summary of a UK national survey prepared for the Royal College of Physicians Committee on Endocrinology and Diabetes. J R Coll Physicians Lond 26: 348-351.
4. Beierwaltes WH 1978 The treatment of hyperthyroidism with iodine-131. Semin Nucl Med 8: 95-103.
5. Bockisch A, Jamitzky T, Derwanz R, Biersack HJ, 1993 Optimized dose planning of radioiodine therapy of benign thyroidal diseases. J Nucl Med 34: 1632-1638.
6. Leslie WD, Ward L, Salamon EA, Ludwig S, Rowe RC, Cowden EA, 2003 A randomized comparison of radioiodine doses in Graves' hyperthyroidism. J Clin Endocrinol Metab 88: 978-983.
7. Peters H, Fischer C, Bogner U, Reiners C, Schleusener H, 1995 Radioiodine therapy of Graves' hyperthyroidism: standard vs. calculated 131iodine activity. Results from a prospective, randomized, multicentre study. Eur J Clin Invest 25: 186-193.
8. Berg G, Michanek A, Holmberg E, Nystrom E, 1996, Clinical outcome of radioiodine treatment of hyperthyroidism: a follow-up study. J Intern Med 239: 165-171.
9. Girgensohn S, Liedtke R, Balzer G, Castor S, Hauser M, 1997, Performance of the ACS: Centaur high-capacity, random-access immunoassay system. Clin Lab 43: 975-83.
10. Hedley AJ, Lazarus JH, McGhee SM, et al, 1992, Treatment of hyperthyroidism by radioactive iodine. Summary of a UK national survey prepared for the Royal College of Physicians Committee on Endocrinology and Diabetes. J R Coll Physicians Lond 26: 348-351.
11. de Bruin TW, Croon CD, de Klerk JM, van Isselt JW, 1994 Standardized radioiodine therapy in Graves' disease: the persistent effect of thyroid weight and radioiodine uptake on outcome. J Intern Med 236: 507-513.
12. Safe AF, Maxwell RT, 1990, Efficiency of treatment and monitoring of ablative radio iodine therapy for hyperthyroidism: a DGH centre study. Br J Clin Pract 44: 393-395.
13. Jarlov AE, Hegedus L, Kristensen LO, Nygaard B, Hansen JM, 1995, Is calculation of the dose in radioiodine therapy of hyperthyroidism worth while? Clin Endocrinol (Oxf) 43: 325-329.
14. Kung AW, Pun KK, Lam KS, Choi P, Wang C, Yeung RT, 1990, Long-term results following 131I treatment for Graves' disease in Hong Kong Chinese-discriminant factors predicting hypothyroidism. Q J Med 76: 961-967.
15. Dobyns BM, Sheline GE, Workman JB, Tompkins EA, McConahey WM, Becker DV, 1974 Malignant and benign neoplasms of the thyroid in patients treated for hyperthyroidism: a report of the cooperative thyrotoxicosis therapy follow-up study. J Clin Endocrinol Metab 38: 976-998.
16. Holm LE, Hall P, Wiklund K, et al, 1991 Cancer risk after iodine-131 therapy for hyperthyroidism. J Natl Cancer Inst 83: 1072-1077.
17. Medical and dental guidance notes: A good practice guide on all aspects of ionising radiation in the clinical environment. York: Institute of Physics and Engineering in Medicine, 2002.
18. Mourits MP, Koornneef L, Wiersinga WM, Prummel MF, Berghout A, van der Gaag R, 1989 Clinical criteria for the assessment of disease activity in Graves' ophtalmopathy: a novel approach. Br J Ophtalmol 73: 639-644.
19. Cunnien AJ, Hay ID, Gorma CA, et al, 1982 Radioiodine induced hypothyroidism in Graves' disease: factors associated with the increasing incidence. J Nucl Med 23: 978-983.
20. McDermott MT, Kidd GS, Dodson LE, et al, 1983 Radioiodine induced thyroid storm. Am J Med 75: 353-355.
21. Connell JM, Hilditch TE, McCruden DC, Robertson J, Alexander WD, 1984 Effect of pretreatment with carbimazole on early outcome following radio-iodine (131I) therapy. Eur J Nucl Med 9: 464-466.
22. ICRP Publication 99, 2006 Low-dose extrapolation of radiation related cancer risk. Annals of the ICRP 35:4. Elsevier, UK.